Momentum Bioscience Ltd

Momentum Bioscience specialises in developing rapid diagnostics for bloodstream infections in patients with suspected sepsis. Our flagship technology, SepsiSTAT®, provides actionable, direct-from-blood results within hours, outpacing traditional methods. Founded in 2008, Momentum Bioscience is committed to revolutionising diagnostic timelines for critical clinical specimens in hospital microbiology laboratories. Supported by our founders, business angels, and venture capital, we operate from our headquarters at Milton Park, Oxfordshire, UK. We are currently seeking partners for joint commercialisation to help deliver our game-changing solutions to patients worldwide.